Erythropoietin (EPO) Affords More Potent Cardioprotection by Activation of Distinct Signaling to Mitochondrial Kinases Compared with Carbamylated EPO

Author： Sato Takahiro   Tanno Masaya   Miki Takayuki   Yano Toshiyuki   Sato Tatsuya   Shimamoto Kazuaki   Miura Tetsuji  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.24, Iss.5-6, 2010-12, pp. : 401-408

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human recombinant erythropoietin (rhEPO) may provide myocardial protection during resuscitation from ventricular fibrillation

By  

Inpharma, Vol. 1, Iss. 1603, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics

By Bittner B.   Morlock M.   Koll H.   Winter G.   Kissel T.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 45, Iss. 3, 1998-05 ,pp. : 295-305

Elsevier

Access to resources Recommend Favorite

Erythropoietin: From Hematopoiesis to Cardioprotection

By Meer Peter   Lipsic Erik   Gilst Wiek   Veldhuisen Dirk  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 1, 2005-01 ,pp. : 7-8

Springer Publishing Company

Access to resources Recommend Favorite

Molecular Basis of Cardioprotection by Erythropoietin

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 56-69

Bentham Science Publishers

Access to resources Recommend Favorite

Self-dissolving microneedles for the percutaneous absorption of EPO in mice

By Ito Yukako   Yoshimitsu Jun-Ichiro   Shiroyama Keiji   Sugioka Nobuyuki   Takada Kanji  

Journal of Drug Targeting, Vol. 14, Iss. 5, 2006-06 ,pp. : 255-261

Informa Healthcare

Access to resources Recommend Favorite